We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Portable Cardiac Marker System Aids Diagnosis

By HospiMedica staff writers
Posted on 12 Mar 2007
A new portable cardiac marker system is designed for on the spot point-of-care testing (POCT) cardiovascular diagnoses, aiding fast treatment decisions.

The cobas h 232 is a small, self-contained, portable analyzer intended for rapid, on-site determination of the important cardiac markers--N-terminal brain natriuretic peptide (NT-proBNP), troponin T, CK-MB, myoglobin, and D-Dimer. More...
By providing diagnostic information directly on the spot, the system helps in the assessment of symptoms indicative not only of cardiovascular conditions such as acute coronary syndrome (ACS) and heart failure, but also thromboembolic events, such as in patients presenting with such symptoms as chest pain or severe shortness of breath in the emergency room.

The system is maintenance-free and offers different levels of customizable quality control and data management features required for documentation and quality assurance in POCT. The analyzer is designed for use with pre-calibrated single-use test strip assays that are standardized to laboratory reference methods. Requiring only a single whole blood sample, the cobas h 232 system's touch-screen user interface guides the user during test handling, and the test result is provided within minutes.

The cobas h 232 is a product of Roche Diagnostics (Basel, Switzerland). When connected to the Roche cobas IT 1000, a web-based POCT data management system that serves to collect and analyze the test results, the system offers effective remote management, enhanced workflow efficiency, and enhancements in quality assurance.

"I am proud that we are now able to offer the easy-to-use, handheld cobas h 232 point-of-care system for cardiovascular diagnosis that offers healthcare professionals in hospitals, as well as general practitioners, access to fast diagnostic results. Patients will benefit from rapid diagnosis and treatment decisions based on the health information provided, said Dr. Volker Pfahlert, head of Roche professional diagnostics.




Related Links:
Roche Diagnostics

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Silver Member
ECG Management System
NEMS Web
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.